ALYSSA EVERSON: Open Payments
NPI 1093335796 · BURNSVILLE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 17 payments from 15 companies in 2025. Trend: 2023 $136 · 2024 $420 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $48 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| NS Pharma, Inc. | 1 | $39 |
| Alexion Pharmaceuticals, Inc. | 1 | $29 |
| Biogen, Inc. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Neurelis, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $17 |
Products named: Leqembi, Symbravo, VILTEPSO, ULTOMIRIS, KESIMPTA, VALTOCO, REXULTI, KEVEYIS.
Industry payments across MN — which companies pay providers there.
